Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

101. Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index

Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index Final Update Summary: Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment With the Ankle-Brachial Index - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Summary Peripheral Artery Disease and Cardiovascular Disease: Screening and Risk Assessment (...) With the Ankle-Brachial Index Release Date: July 2018 Recommendation Summary Population Recommendation Grade Adults The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for peripheral artery disease (PAD) and cardiovascular disease (CVD) risk with the ankle-brachial index (ABI) in asymptomatic adults. See the for suggestions for practice regarding the I statement. To read the recommendation statement in JAMA , select . To read the evidence

U.S. Preventive Services Task Force2018

102. Osteoporosis to Prevent Fractures: Screening

Osteoporosis to Prevent Fractures: Screening Final Update Summary: Osteoporosis to Prevent Fractures: Screening - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Summary Osteoporosis to Prevent Fractures: Screening Osteoporosis to Prevent Fractures: Screening Release Date: June 2018 Recommendation Summary Population Recommendation Grade Women 65 years and older The USPSTF recommends screening (...) for osteoporosis with bone measurement testing to prevent osteoporotic fractures in women 65 years and older. Postmenopausal women younger than 65 years at increased risk of osteoporosis The USPSTF recommends screening for osteoporosis with bone measurement testing to prevent osteoporotic fractures in postmenopausal women younger than 65 years who are at increased risk of osteoporosis, as determined by a formal clinical risk assessment tool. See the for information on risk assessment. Men The USPSTF concludes

U.S. Preventive Services Task Force2018

103. 5 Things to know about screening for suicide risk in primary care

5 Things to know about screening for suicide risk in primary care 5 Things to know about screening for suicide risk in primary care Toggle navigation Shared more. Cited more. Safe forever. Toggle navigation View Item JavaScript is disabled for your browser. Some features of this site may not work without it. Search MOspace This Collection Browse Statistics 5 Things to know about screening for suicide risk in primary care View/ Open Date 2015-07 Format Metadata Abstract Suicide is the 10th

Evidence Based Practice 2018

104. Qualitative study of Ebola screening at ports of entry to the UK

Qualitative study of Ebola screening at ports of entry to the UK 29989094 2018 11 14 2059-7908 3 3 2018 BMJ global health BMJ Glob Health Qualitative study of Ebola screening at ports of entry to the UK. e000788 10.1136/bmjgh-2018-000788 In response to the 2013-2016 West African outbreak of the Ebola virus disease (EVD), Public Health England introduced enhanced screening at major UK ports of entry. Our aim was to explore screeners' and screened travellers' perceptions of screening as part (...) of an evaluation of the screening programme. We undertook qualitative focus groups and semistructured interviews with screeners and travellers who had returned from affected countries before and after the introduction of screening in England. The study was conducted in two airports: one international rail terminal and one military airport. Research topic guides explored perceptions of the purpose and implementation of the process, potential improvements and reactions to screening. The data were analysed using

BMJ global health2018 Full Text: Link to full Text with Trip Pro

105. Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert

Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert 29984203 2018 11 14 2450-131X 6 2 2018 Jun Journal of translational internal medicine J Transl Int Med Hepatitis C Screening in Commercially Insured U.S. Birth-cohort Patients: Factors Associated with Testing and Effect of an EMR-based Screening Alert. 82-89 10.2478/jtim-2018-0012 Hepatitis C virus (HCV) testing rates among U.S. birth-cohort (...) patients have been studied extensively, limited data exists to differentiate birth-cohort screening from risk- or liver disease-based testing. This study aims to identify factors associated with HCV antibody (HCV-Ab) testing in a group of insured birth cohort patients, to determine true birth cohort testing rates, and to determine whether an electronic medical record (EMR)-driven Best Practice Alert (BPA) would improve birth cohort testing rates. All birth-cohort outpatients between 2010 and 2015 were

Journal of translational internal medicine2018 Full Text: Link to full Text with Trip Pro

106. Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening.

Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening. The toll of inadequate health care is well-substantiated, but recognition is mounting that "too much" is also possible. Overdiagnosis represents one harm of too much medicine, but the concept can be confusing: It is often conflated with related harms (such as overtreatment, misclassification, false-positive results, and overdetection) and is difficult to measure because it cannot be directly observed. Because the U.S (...) . Preventive Services Task Force (USPSTF) issues screening recommendations aimed largely at healthy persons, it has a particular interest in understanding harms related to screening, especially but not limited to overdiagnosis. In support of the USPSTF, the authors summarize the knowledge and provide guidance on defining, estimating, and communicating overdiagnosis in cancer screening. To improve consistency, thinking, and reporting about overdiagnosis, they suggest a specific definition. The authors

Annals of Internal Medicine2018

107. Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Importance: Osteoporotic fractures cause significant morbidity and mortality. Objective: To update the evidence on screening and treatment to prevent osteoporotic fractures for the US Preventive Services Task Force. Data Sources: PubMed, the Cochrane Library, EMBASE, and trial registries (November 1, 2009, through October 1, 2016) and surveillance (...) of the literature (through March 23, 2018); bibliographies from articles. Study Selection: Adults 40 years and older; screening cohorts without prevalent low-trauma fractures or treatment cohorts with increased fracture risk; studies assessing screening, bone measurement tests or clinical risk assessments, pharmacologic treatment. Data Extraction and Synthesis: Dual, independent review of titles/abstracts and full-text articles; study quality rating; random-effects meta-analysis. Main Outcomes and Measures

JAMA2018

108. Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.

Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement. Importance: By 2020, approximately 12.3 million individuals in the United States older than 50 years are expected to have osteoporosis. Osteoporotic fractures, particularly hip fractures, are associated with limitations in ambulation, chronic pain and disability, loss of independence, and decreased quality of life, and 21% to 30% of patients who experience a hip fracture die within 1 (...) year. The prevalence of primary osteoporosis (ie, osteoporosis without underlying disease) increases with age and differs by race/ethnicity. With the aging of the US population, the potential preventable burden is likely to increase in future years. Objective: To update the 2011 US Preventive Services Task Force (USPSTF) recommendation on screening for osteoporosis. Evidence Review: The USPSTF reviewed the evidence on screening for and treatment of osteoporotic fractures in men and women, as well

JAMA2018

109. Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin

Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin 29951225 2018 11 14 2056-7944 3 2018 NPJ genomic medicine NPJ Genom Med Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary origin. 15 10.1038/s41525-018-0055-6 Precision

NPJ genomic medicine2018 Full Text: Link to full Text with Trip Pro

110. Benefits and harms of screening men for abdominal aortic aneurysm in Sweden: a registry-based cohort study.

Benefits and harms of screening men for abdominal aortic aneurysm in Sweden: a registry-based cohort study. BACKGROUND: Large reductions in the incidence of abdominal aortic aneurysm (AAA) and AAA-related mortality mean that results from randomised trials of screening for the disorder might be out-dated. The aim of this study was to estimate the effect of AAA screening in Sweden on disease-specific mortality, incidence, and surgery. METHODS: Individual data on the incidence of AAA, AAA (...) mortality, and surgery for AAA in a cohort of men aged 65 years who were invited to screening between 2006 and 2009, were compared with data from an age-matched contemporaneous cohort of men who were not invited for AAA screening. We also analysed national data for all men aged 40-99 years between Jan 1, 1987, and Dec 31, 2015, to explore background trends. Adjustment for confounding was done by weighting the analyses with a propensity score obtained from a logistic regression model on cohort year

Lancet2018

111. Pharmacist-led screening in sexually transmitted infections: current perspectives

Pharmacist-led screening in sexually transmitted infections: current perspectives 29942790 2018 11 14 2230-5254 7 2018 Integrated pharmacy research & practice Integr Pharm Res Pract Pharmacist-led screening in sexually transmitted infections: current perspectives. 67-82 10.2147/IPRP.S140426 Sexually transmitted infection (STI) screening is a crucial initiative that aims to reduce the increasing global prevalence of many common STIs such as chlamydia, gonorrhea, and herpes simplex virus (HSV (...) ). Many STIs are either asymptomatic or show mild symptoms that are often attributed to other infections; hence, screening is the only way to identify - and by extension, treat - them. In this way, the spread of STIs can be reduced, and the health implications of an untreated STI are minimized. Community pharmacies could provide an avenue to convenient, confidential STI screening by using noninvasive or minimally invasive sample collection techniques that are used by the consumer or pharmacist. We

Integrated pharmacy research & practice2018 Full Text: Link to full Text with Trip Pro

112. Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: A Mixed-Method Analysis

Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: A Mixed-Method Analysis 30084698 2018 12 07 2378-9506 4 2018 Jul Journal of global oncology J Glob Oncol Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: A Mixed-Method Analysis. 1-10 10.1200/JGO.17.00228 Purpose Cervical cancer is an important cause of mortality in low- and middle-income countries. Although screening technologies continue to improve (...) , systems of care remain fragmented. It is important to better understand factors that affect use of screening services and loss to follow-up along the care continuum. Methods We conducted a mixed-methods study of a cytology-based screening program in rural Guatemala. A retrospective electronic chart review was performed on data from all patients from 2013 to 2014. We analyzed progression through care and calculated loss-to-follow-up rates. We also analyzed the prior experiences of patients

Journal of global oncology2018 Full Text: Link to full Text with Trip Pro

113. Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.

Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force. Importance: Cardiovascular disease (CVD) is the leading cause of death in the United States. Objective: To review the evidence on screening asymptomatic adults for CVD risk using electrocardiography (ECG) to inform the US Preventive Services Task Force. Data Sources: MEDLINE, Cochrane Library, and trial registries through May (...) of abstracts, full-text articles, and study quality; qualitative synthesis of findings. Main Outcomes and Measures: Mortality, cardiovascular events, reclassification, calibration, discrimination, and harms. Results: Sixteen studies were included (N = 77 140). Two RCTs (n = 1151) found no significant improvement for screening with exercise ECG (vs no screening) in adults aged 50 to 75 years with diabetes for the primary cardiovascular composite outcomes (hazard ratios, 1.00 [95% CI, 0.59-1.71] and 0.85 [95

JAMA2018

114. Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.

Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement. Importance: Cardiovascular disease (CVD), which encompasses atherosclerotic conditions such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease, is the most common cause of death among adults in the United States. Treatment to prevent CVD events by modifying risk factors is currently informed by CVD risk assessment with tools (...) such as the Framingham Risk Score or the Pooled Cohort Equations, which stratify individual risk to inform treatment decisions. Objective: To update the 2012 US Preventive Services Task Force (USPSTF) recommendation on screening for coronary heart disease with electrocardiography (ECG). Evidence Review: The USPSTF reviewed the evidence on whether screening with resting or exercise ECG improves health outcomes compared with the use of traditional CVD risk assessment alone in asymptomatic adults. Findings

JAMA2018

115. Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation

Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation 29951486 2018 11 14 2297-055X 5 2018 Frontiers in cardiovascular medicine Front Cardiovasc Med Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. 63 10.3389/fcvm.2018.00063 Aim: To assess the accuracy of multi

Frontiers in cardiovascular medicine2018 Full Text: Link to full Text with Trip Pro

116. Attention, arousal and other rapid bedside screening instruments for delirium in older patients: a systematic review of test accuracy studies

Attention, arousal and other rapid bedside screening instruments for delirium in older patients: a systematic review of test accuracy studies 29697753 2018 04 26 1468-2834 2018 Apr 25 Age and ageing Age Ageing Attention, arousal and other rapid bedside screening instruments for delirium in older patients: a systematic review of test accuracy studies. 10.1093/ageing/afy058 delirium occurs frequently in frail patients but is easily missed. Screening with a rapid, easy-to-use and highly sensitive (...) instrument might help improve recognition. The aim of this study was to review attention, arousal and other rapid bedside screening instruments for delirium in older patients. a literature search was performed in PubMed, PsycINFO and Embase. We scrutinized forward citations in Google Scholar, and references of included articles and prior reviews. We included studies among older patients that investigated the sensitivity and specificity of delirium screening instruments that could be administered in 3 min

EvidenceUpdates2018

117. Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings

Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings 29759965 2018 06 13 1488-2329 190 19 2018 05 14 CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne CMAJ Screening for impaired vision in community-dwelling adults aged 65 years and older in primary care settings. E588-E594 10.1503/cmaj.171430 Wilson Brenda J BJ School of Epidemiology and Public Health (Wilson), University of Ottawa, Ottawa, Ont

EvidenceUpdates2018 Full Text: Link to full Text with Trip Pro

118. What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis

What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis What works to increase attendance for diabetic retinopathy screening? An evidence synthesis and economic analysis Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find (...) the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> {{metadata.Title}} {{metadata.Headline}} Quality improvement incorporating behaviour change techniques increased diabetic retinopathy screening attendance by 12% on average compared with usual care, with a high probability of being cost-effective at a societal willingness to pay threshold of £20,000/QALY. {{author}} {{($index , , , , , , , , , , , & . John G Lawrenson 1, * , Ella Graham-Rowe 2 , Fabiana Lorencatto 2 , Stephen

NIHR HTA programme2018

119. Cardiovascular Disease Risk: Screening With Electrocardiography

Cardiovascular Disease Risk: Screening With Electrocardiography Final Recommendation Statement: Cardiovascular Disease Risk: Screening With Electrocardiography - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 3/6/2018 4:20:40 PM You are here: Final Recommendation Statement : Final Recommendation Statement Final Recommendation Statement Cardiovascular Disease Risk: Screening With Electrocardiography Recommendations made by the USPSTF (...) are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. Recommendation Summary Population Recommendation Grade Adults at low risk of CVD events The USPSTF recommends against screening with resting or exercise electrocardiography (ECG) to prevent cardiovascular disease (CVD) events in asymptomatic adults at low risk of CVD events. Adults at intermediate or high risk of CVD

U.S. Preventive Services Task Force2018

120. A High-yield Fall Risk and Adverse Events Screening Questions From the Stopping Elderly Accidents, Death, and Injuries (STEADI) Guideline for Older Emergency Department Fall Patients

A High-yield Fall Risk and Adverse Events Screening Questions From the Stopping Elderly Accidents, Death, and Injuries (STEADI) Guideline for Older Emergency Department Fall Patients 29575248 2018 05 30 1553-2712 2018 Mar 25 Academic emergency medicine : official journal of the Society for Academic Emergency Medicine Acad Emerg Med A High-yield Fall Risk and Adverse Events Screening Questions From the Stopping Elderly Accidents, Death, and Injuries (STEADI) Guideline for Older Emergency

EvidenceUpdates2018